课题基金 / 基金详情

Protein C pathway function in hematopoiesis

Protein C pathway function in hematopoiesis
蛋白 C 通路在造血中的功能
批准号:
9229562
负责人:
Hartmut Karl-Heinz Weiler
金额:
$41.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-09 至 2019-03-31

项目摘要

项目成果

Hartmut Karl-Heinz Weiler的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This project investigates a previously unknown function of the blood coagulation regulator Thrombomodulin and the natural protein C pathway in the hematopoietic stress response to radiation-injury and chemotherapy. We found that the endogenous Thbd- protein C pathway is required for the efficient recovery of hematopoiesis after lethal radiation exposure, and that pharmacologic supplementation of protein C pathway function prevents death caused by radiation-induced bone marrow failure. This proposal investigates the cellular and molecular mechanism mediating this newly discovered function of the Thrombomodulin-protein C pathway. Aim 1 identifies the as yet unknown relevant stromal and hematopoietic cell populations that express Thrombomodulin in normal bone marrow and in bone marrow exposed to myeloablative stress (radiation- injury and chemotherapy). Aim 2 tests the hypothesis that Thrombomodulin expression in stromal endothelium of the bone marrow is necessary for the normal recovery of hematopoiesis after myelosuppression; and that this effect of Thrombomodulin is based on its ability to augment in an EPCR- and PAR1-dependent manner the tie2- angiopoietin1-mediated recovery of the vascular stem cell niche. Aim 3 investigates the functional role of Thrombomodulin in hematopoietic stem and progenitor cells. This function is likely different from its role in endothelial cells and may involve the regulationof the supportive function of stromal macrophages in hematopoietic recovery from myelosuppression, as well as the cell-autonomous enhancement of myelopoiesis. Aim 4 delineates the contributions of aPC's anticoagulant and cell signaling functions to its therapeutic efficacy in supporting hematopoietic recovery from myeloablation. These studies will document a new physiologic connection between blood coagulation and hematopoiesis, and have the potential to significantly impact the current understanding of hematopoiesis and approaches to its pharmacologic manipulation.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation.
组织选择性和时间控制 Thbd 基因失活后,成年小鼠血栓形成的可变表型外显率。
DOI: 10.1182/bloodadvances.2017005058
发表时间: 2017
期刊: Blood advances
影响因子: 7.5
作者: [vanMens,ThijsE, Liang,Hai-PoH, Basu,Sreemanti, Hernandez,Irene, Zogg,Mark, May,Jennifer, Zhan,Min, Yang,Qiuhui, Foeckler,Jamie, Kalloway,Shawn, Sood,Rashmi, Karlson,CarenSue, Weiler,Hartmut]
通讯作者: Weiler,Hartmut
Core B: Glyco-genomics and Bioinformatics
  • 批准号:
    10321578
  • 项目类别:
  • 资助金额:
    $23.27万
  • 财政年份:
    2021
  • 负责人:
    Hartmut Karl-Heinz Weiler
  • 依托单位:
Core B: Glyco-genomics and Bioinformatics
  • 批准号:
    10545007
  • 项目类别:
  • 资助金额:
    $25.86万
  • 财政年份:
    2021
  • 负责人:
    Hartmut Karl-Heinz Weiler
  • 依托单位:
Core B: Glyco-genomics and Bioinformatics
  • 批准号:
    10088966
  • 项目类别:
  • 资助金额:
    $27.25万
  • 财政年份:
    2021
  • 负责人:
    Hartmut Karl-Heinz Weiler
  • 依托单位:
Core C: Animal Models Core
  • 批准号:
    10379434
  • 项目类别:
  • 资助金额:
    $14.81万
  • 财政年份:
    2019
  • 负责人:
    Hartmut Karl-Heinz Weiler
  • 依托单位:
海外基金